Faron Pharmaceuticals Oy (AIM: FARN)
Health Care · Biotechnology · FI
£0.41
+3.54% today · -81.6% 1Y
Faron Pharmaceuticals Oy (AIM: FARN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $125.37M.
Over the last twelve months the share price has lost 81.6%, trading between 0.37 and 2.40.
Tweenvest scores Faron Pharmaceuticals Oy across four factors: quality 17/100. Its strongest factor is quality.
FARN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $125.37M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.24
- Dividend yield
- —
- Beta (5Y)
- 1.12
- 52-week high
- £2.40
- 52-week low
- £0.37
- Avg volume (3M)
- —
- Shares outstanding
- 224.35M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.